Focused specifically on Life Science Start-Ups
Examines how to determine a company valuation and future "fundable milestones"
Explores how to align regulatory and clinical strategies
Discusses intellectual property derived from a university or individual through formation to exit.
Reviews how start-ups must simultaneously meet the needs of multiple constituencies at once: investors, regulators, customers and exit candidates